Human RPL7 and DDX21 function synergistically with HTLV-1 Gag to overcome genomic RNA structural barriers that block tRNAPro primer annealing
Nucleic Acids Research · 03.07.2026 · 54 (13)
DOI: 10.1093/nar/gkag680 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 14.07.2026. Verfasst von Yu-Ci Syu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Molecular, Cellular, and Developmental Biology Graduate Program, Department of Chemistry and Biochemistry, Center for RNA Biology, and Center for Ret…. Hauptthemen laut MEDLINE: Human T-lymphotropic virus 1, Ribosomal Proteins, DEAD-box RNA Helicases, Gene Products, gag. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Human T-cell leukemia virus type 1 (HTLV-1), an oncogenic retrovirus, uses human tRNAPro to prime reverse transcription. How tRNAPro is annealed to the primer-binding site (PBS), which is embedded in a stable hairpin structure in the genomic RNA, remains unclear. In contrast to human immunodeficiency virus type 1 (HIV-1) nucleocapsid (NC) protein, which robustly chaperones transfer RNA (tRNA) annealing to the HIV-1 PBS, HTLV-1 NC protein displays very weak chaperone function. Recombinantly-purified HTLV-1 Gag was only slightly more effective at chaperoning the annealing of tRNAPro to the PBS than NC protein. To identify potential HTLV-1 Gag interacting co-chaperones in cells, we performed affinity tagging/purification–mass spectrometry. Two significant hits, ribosomal protein L7 (RPL7) and DDX21, were validated by reciprocal co-IP studies in cells. Domain mapping revealed that HTLV-1 Gag interacts with RPL7 and DDX21 through the zinc fingers of NC protein in an RNA-independent fashion. Both RPL7 and DDX21 are packaged into virions, and each protein alone was more effective than HTLV-1 Gag at annealing tRNAPro to the PBS. Further synergistic effects were observed for the Gag/RPL7/DDX21 combination in overcoming structural constraints at the PBS to promote tRNAPro annealing. The mechanistic insights gained from these studies may be exploited for the development of new therapeutic strategies aimed at targeting HTLV-1 RT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Molecular, Cellular, and Developmental Biology Graduate Program, Department of Chemistry and Biochemistry, Center for RNA Biology, and Center for Retrovirus Research, Ohio State University, Columbus, OH 43210,United Sta…
ORCID-Profile: Karin Musier-Forsyth
Förderung
- NIAID NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Syu, Y. C., Long, Z., & Musier-Forsyth, K. (2026). Human RPL7 and DDX21 function synergistically with HTLV-1 Gag to overcome genomic RNA structural barriers that block tRNAPro primer annealing. Nucleic Acids Research, 54(13). https://doi.org/10.1093/nar/gkag680
Vancouver
Syu YC, Long Z, Musier-Forsyth K. Human RPL7 and DDX21 function synergistically with HTLV-1 Gag to overcome genomic RNA structural barriers that block tRNAPro primer annealing. Nucleic Acids Research. 2026;54(13). doi:10.1093/nar/gkag680
BibTeX
@article{Syu2026,
author = {Syu, Yu-Ci and Long, Zixi and Musier-Forsyth, Karin},
title = {Human RPL7 and DDX21 function synergistically with HTLV-1 Gag to overcome genomic RNA structural barriers that block tRNAPro primer annealing},
journal = {Nucleic Acids Research},
year = {2026},
volume = {54},
number = {13},
doi = {10.1093/nar/gkag680}
}
EUVIMED